Back to Homepage

www.enjoypath.com

Uploaded: 2009-10-27, Updated: 2008-10-27

Hepatosplenic Gamma-Delta T-Cell Lymphoma (HSTL)

CLINICAL FEATURES

  • Very rare. Young male, median age 35 years, 86% males.

  • ~20% arise in immune suppression.

  • Hepatosplenomegaly, consistently BM involvement, no lymphadenopathy.

  • Moderate anemia, marked thrombocytopenia. PB involvement uncommon at presentation, may occur later in the clinical course.

GROSS FINDINGS

  • The spleen is enlarged with diffuse involvement in the red pulp, without any gross lesions. Diffuse hepatomegaly is also present.

MICROSCOPIC FINDINGS
  • Tumor cells involve the splenic red pulp, hepatic sinusoids and bone marrow sinuses.
  • Monotonous medium sized tumor cells with scant to moderate clear cytoplasm, round/oval nuclei, slightly dispersed chromatin, small inconspicuous nucleoli.
  • Bone marrow aspirate smears contain malignant cells resembling blasts, occasionally with fine cytoplasmic granules.

IMMUNOPHENTYPE
  • CD2+, CD3+, CD7+, CD56+, CD57+, TIA-1+, CD40L+.
  • CD4-, CD5-, variable CD8, TCR alpha/beta-

CYTOGENETIC STUDIES
  • Positive for gamma-delta TCR, negative for alpha-beta TCR.

TREATMENT AND PROGNOSIS
  • Aggressive, mostly die with 2 years.

CASE STUDIES: HP-105

REFERENCES: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. 2008.